Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 11 - 10    tags : Alzheimer    save search

AC Immune Alzheimer’s Drug Reduces Cognitive Decline but Misses Functional En...
Published: 2021-11-10 (Crawled : 21:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.09% H: 1.42% C: 1.07%

alzheimer drug alzheimer’s alzheimer's
AC Immune Alzheimer’s Drug Reduces Cognitive Decline but Misses Functional Endpoints
Published: 2021-11-10 (Crawled : 21:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.09% H: 1.42% C: 1.07%

alzheimer drug alzheimer’s alzheimer's
Eisai Presents Late-Breaker Updates On Lecanemab Clinical, Biomarker And Safety Data From Phase 2b Study Core And Open-Label Extension Across Five Years At Clinical Trials On Alzheimer's Disease (CTAD) Conference
Published: 2021-11-10 (Crawled : 21:00) - biospace.com/
BIIB | $194.39 2.03% 1.99% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.44% C: -1.15%

disease alzheimer ema phase 2 clinical trials trials phase 2b trial conference alzheimer’s alzheimer's disease alzheimer's biomarkers lecanemab
Athira Pharma Presents Overview and Update from ACT-AD and LIFT-AD Trials of ATH-1017 in mild-to-moderate Alzheimer’s Disease at CTAD Conference
Published: 2021-11-10 (Crawled : 17:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K twitter stocktwits trandingview |
Health Technology
| | O: -0.65% H: 2.92% C: -3.51%

disease alzheimer ath-1017 trials trial conference alzheimer’s alzheimer's disease alzheimer's
Anavex Life Sciences Announces Participation at Upcoming Lausanne VIII Workshop Panel - Building Global Momentum for Interventions in Alzheimer’s Disease
Published: 2021-11-10 (Crawled : 12:15) - globenewswire.com
AVXL | News | $3.8 0.0% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -7.28% H: 3.35% C: -1.43%

disease alzheimer life science anavex alzheimer’s alzheimer's disease alzheimer's
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.